Monday, September 16, 2024

DD International

Cabinet approves memoranda on health products with Netherlands, Dominican Republic, Ecuador

January 18, 2024 9:11 PM IST

Ecuador | health MOus | india netherlands

India has taken substantial strides in fortifying international partnerships in medical product regulation, marking a significant development with the signing of three crucial Memoranda of Understanding (MoUs).

India sign MoI with Netherlands

In a meeting between Bhagwant Khuba, Union Minister of State for Chemicals and Fertilizers, and Ernst Kuipers, Minister of Health, Welfare, and Sports of the Kingdom of Netherlands, a Memorandum of Intent (MoI) was signed to elevate cooperation on medical product regulation. The agreement aims to improve the quality of medical products and healthcare services for both nations. Khuba, leading an Indian delegation, participated in the second World Local Production Forum in The Hague, emphasizing the importance of increasing access to medicines globally.

Further strengthening India’s ties, Khuba visited the European Medicines Agency (EMA) and engaged in discussions about pharmaceutical and medical technology regulations with Carla van Rooijen, Director of the Pharmaceuticals and Medical Technology Division.

MoUs with Ecuador and the Dominican Republic

Additionally, the Union Cabinet, chaired by Prime Minister Narendra Modi, was apprised of two more crucial MoUs. One, signed with Agencia Nacional de Regulaction, Control Y Vigilancia Sanitria – ARCSA of Ecuador, and the other with the Directorate General for Medicine, Foods, and Sanitary Products Organizations of the Dominican Republic. These agreements focus on cooperation in the field of Medical Products Regulation, aiming to enhance understanding of regulatory aspects, promote international cooperation, and coordinate efforts in relevant fora.

Role of CDSCO in Collaborations

The Central Drugs Standard Control Organization (CDSCO), India’s National Regulatory Authority for drugs, medical devices, and cosmetics, plays a pivotal role in these collaborations. The convergence in regulatory practices expected from these MoUs is anticipated to boost the export of medicines from India, creating employment opportunities and contributing to the vision of an Atmanirbhar Bharat.

These strategic partnerships signify India’s commitment to global health standards and the facilitation of medical product exports, aligning with Prime Minister Modi’s vision for a self-reliant and globally influential India.

 

Copyright © 2024 DD India. All rights reserved

Visitors: 2032880

Last updated on: 16th September 2024